$AORT Cashflow Statement | Understand Stock

$AORT

$22.98 +$0.00 (0.0%) After hours

$AORT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Net cash flows from operating activities:
Net income (loss)
Adjustments to reconcile net income (loss) to net cash from operating activities:
Depreciation and amortization
Non-cash compensation
Non-cash lease expense
Write-down of inventories and deferred preservation costs
Non-cash interest expense
Write-off of Endospan Option
Deferred income taxes
Change in fair value of contingent consideration
Endospan fair value adjustments
Losses on inducement/extinguishment of debt
Gain from sale of non-financial assets
Other
Changes in operating assets and liabilities:
Receivables
Inventories and deferred preservation costs
Prepaid expenses and other assets
Accounts payable, accrued expenses, and other liabilities
Net cash flows provided by operating activities
Net cash flows from investing activities:
Capital expenditures
Other
Payments under Endospan agreements
Proceeds from sale of non-financial assets, net
Payments for Endospan agreement
Ascyrus Acquisition, net of cash acquired
Acquisition of intangible assets
Net cash flows used in investing activities

Net cash flows from financing activities:
Proceeds from issuance of long-term debt
Proceeds from revolving credit facility
Repayment of revolving line of credit
Repayment of debt
Proceeds from exercise of stock options and issuance of common stock
Proceeds from issuance of convertible debt
Payment of debt issuance costs
Proceeds from financing insurance premiums
Payment of contingent consideration
Principal payments on short-term notes payable
Redemption and repurchase of stock to cover tax withholdings
Other
Net cash flows provided by financing activities

Effect of exchange rate changes on cash and cash equivalents
Increase (decrease) in cash and cash equivalents
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year

Comments